Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01386580 |
Title | An Open-label, Phase I/IIa, Dose Escalating Study of 2B3-101 in Patients With Solid Tumors and Brain Metastases or Recurrent Malignant Glioma. |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | to-BBB technologies B.V. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA | NLD | FRA | BEL |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
UNC Lineberger Comprehensive Cancer Center | Chapel Hill | North Carolina | 27599 | United States | Details | |
Universitair Ziekenhuis Antwerpen | Antwerp | B-2650 | Belgium | Details | ||
Jules Bordet Institute | Brussels | B-1000 | Belgium | Details | ||
Institut Curie | Paris | Paris Cedex 05 | 75248 | France | Details | |
Institut Gustave Roussy | Villejuif | Val de Marne | 94805 | France | Details | |
Antoni van Leeuwenhoek Ziekenhuis | Amsterdam | 1066 CX | Netherlands | Details | ||
Vrije Universiteit medisch centrum (Vumc) | Amsterdam | 1081 HV | Netherlands | Details | ||
Leids Universitair Medisch Centrum (LUMC) | Leiden | 2333 CA | Netherlands | Details | ||
Maastricht Universitair Medisch Centrum | Maastricht | 6229 HX | Netherlands | Details | ||
Erasmus MC | Rotterdam | 3075 EA | Netherlands | Details |